Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool August 24, 2010 David Meier	Could Qualcomm Be a Multibagger? Strong returns on equity can generate powerful returns for shareholders.
The Motley Fool August 24, 2010 David Meier	Could Bristol-Myers Squibb Be a Multibagger? Strong returns on equity can generate powerful returns for shareholders.
The Motley Fool August 25, 2010 David Meier	Can MedcoHealth Solutions Produce Big Returns? MedcoHealth Solutions generates incredible returns on equity. Let's see how it does it.
The Motley Fool August 24, 2010 David Meier	Could Alcon Be a Multibagger? Strong returns on equity can generate powerful shareholder returns.
The Motley Fool August 24, 2010 David Meier	Could Amgen Be a Multibagger? Strong returns on equity can generate powerful shareholder returns.
The Motley Fool August 24, 2010 David Meier	Can McKesson Produce Big Returns? McKesson uses its production advantage -- high asset turnover and reasonable leverage -- to generate very attractive returns on equity for shareholders.
The Motley Fool August 24, 2010 David Meier	Can TJX Produce Big Returns? TJX uses its production advantage -- low margins, high asset turnover, and reasonable leverage -- to generate very attractive returns on equity for shareholders.
The Motley Fool August 24, 2010 David Meier	Can Express Scripts Produce Big Returns? Express Scripts generates incredible returns on equity. Let's see how they do it.
The Motley Fool August 18, 2010 David Meier	Here's How Apple Creates Its Advantage Use the DuPont formula to identify where a company's competitive advantage lies.
The Motley Fool August 18, 2010 David Meier	Here's How Sysco Creates Its Advantage Quickly identify where a company's competitive advantage lies.
The Motley Fool August 18, 2010 David Meier	Here's How Target Creates Its Advantage Quickly identify where a company's competitive advantage lies.
The Motley Fool August 18, 2010 David Meier	Here's How The Home Depot Creates Its Advantage Quickly identify where a company's competitive advantage lies.
The Motley Fool August 18, 2010 David Meier	Here's How Wal-Mart Creates Its Advantage Wal-Mart has used its consumer advantage to generate attractive returns on equity.
The Motley Fool August 18, 2010 David Meier	Here's How Amazon.com Creates Its Advantage Identify where a company's competitive advantage lies.
The Motley Fool January 19, 2011 Jim Royal	How Do These Oil Companies Really Boost Their Returns? Let's see what the DuPont formula can tell us about Petrobras and a few of its sector and industry peers
The Motley Fool January 19, 2011 Jim Royal	How Do These Transports Really Boost Their Returns? UPS and FedEx are well-known rivals, but their returns on equity differ sharply.
The Motley Fool January 18, 2011 Jim Royal	How Do These Oil Companies Really Make Their Money? Break down Exxon-Mobil's and some of its peers' return on investment using the Dupont formula.
The Motley Fool November 30, 2010 Jim Royal	How Do These Consumer Goods Companies Really Make Their Money? Let's take a look at Procter & Gamble and a few of its sector and industry peers using the Dupont Formula.
The Motley Fool November 12, 2011 Jim Royal	How Does Staples Boost Its Returns? As investors, we need to understand how our companies truly make their money. A neat trick developed for just that purpose - the DuPont Formula - can help us do so.
The Motley Fool November 30, 2010 Jim Royal	How Do These Software Companies Really Make Their Money? Break it down using the Dupont formula.
The Motley Fool January 18, 2011 Jim Royal	How Does Big Pharma Really Make Its Money? As investors, we need to understand how our companies truly make their money. Thankfully, there's a neat trick developed for just that purpose: the DuPont Formula.
The Motley Fool January 19, 2011 Jim Royal	How Do These Miners Really Boost Their Returns? Let's take a look at BHP Billiton and a few of its sector and industry peers using the DuPont Formula, to see how they actually make their money.
The Motley Fool December 30, 2010 Jim Royal	How Do These Beverage Companies Really Make Their Money? Let's use the Dupont formula to get a better grasp on exactly where Coca-Cola and other beverage companies are producing profit and where they might have a competitive advantage.
The Motley Fool August 18, 2011 Shubh Datta	What You Need to Know About Advance Auto Parts' Return on Equity Delving a little deeper into what is driving Advance's Return on Equity.
The Motley Fool January 18, 2011 Jim Royal	How Do These Biotechs Really Make Their Money? Break it down using the Dupont formula.
The Motley Fool May 25, 2010 Brian Orelli	Medtronic Gets Tossed Out With the Bathwater A bad day to report good news.
The Motley Fool January 18, 2011 Jim Royal	How Does Big Tobacco Really Make Its Money? Breaking down a company's return on equity can often give you some insight into how it's competing against peers and what type of strategy it's using to juice its return on equity.
The Motley Fool May 29, 2008 Brian Orelli	Medtronic Sticks It to Boston Scientific Medtronic wins the medical-device patent duel with Boston Scientific.
The Motley Fool November 21, 2006 Ryan Fuhrmann	Shocking Results at Medtronic Favorable earnings boost shares of this medical equipment maker -- but are they too high already?
The Motley Fool August 10, 2010 Matt Koppenheffer	How'd Frontier Communications Get So Profitable? How did Frontier Communications manage to boost its return on equity?
The Motley Fool February 17, 2009 Brian Orelli	Investors Heart Medtronic The leaner company is more lovable.
The Motley Fool January 18, 2011 Jim Royal	How Do These High-Yielding REITs Really Make Their Money? Let's take a look at Annaly Capital Management and a few of its sector and industry peers using the DuPont formula to see how they really make their money.
The Motley Fool March 8, 2005 Stephen D. Simpson	The Stent Wars Continue Although Boston Scientific and Johnson & Johnson have been beating each other silly for market share, recent clinical data suggest little functional difference between drug-coated stents.
The Motley Fool October 18, 2010 Anand Chokkavelu	There Are Better Opportunities Than Boston Scientific Let's take a look. By the numbers, Abbott, Medtronic, and Johnson & Johnson all look more compelling than Boston Scientific.
The Motley Fool December 30, 2010 Jim Royal	How Do These Telecoms Really Make Their Money? Breaking these telecom companies' returns on equity can give you some insight into how they're competing against peers: AT&T... Vodafone... Verizon... America Movil...
The Motley Fool December 29, 2010 Jim Royal	How Do These Retailers Really Make Their Money? By using the DuPont Formula, you can get a better grasp on exactly where your company is producing its profit and where it might have a competitive advantage. Let's look at Wal-Mart using this criteria.
The Motley Fool October 18, 2010 Gerard Torres	Every Investor Should Know This Stock Tool Use DuPont analysis to breakdown the profitability of stocks.
The Motley Fool August 18, 2008 Brian Orelli	Foolish Forecast: Taking Medtronic to Heart In advance of earnings analysts expect Medtronic, with another medical device approval, to boost revenues 17%.
The Motley Fool July 23, 2008 Brian Orelli	Leaner Boston Scientific Isn't Looking Healthy Investors are rightfully growing weary of Boston Scientific's ability to cut expenses on flat sales, and they send the stock down.
The Motley Fool September 26, 2005 Stephen D. Simpson	Boston Scientific: Finally Cheap Enough? Could shares of the medical device company now be attractive for long-term investors?
The Motley Fool December 31, 2007 Brian Orelli	Boston Scientific Restarts Its Heart Boston Scientific receives European approval for its defibrillator, giving the company a revenue boost even if the U.S. approval is delayed.
The Motley Fool November 15, 2007 Rich Smith	Foolish Forecast: Mulling Medtronic In advance of earnings reports, analysts expect sales from the medical-equipment maker to remain flat and profit to fall slightly.
The Motley Fool April 19, 2005 Stephen D. Simpson	Stent Success Propels Boston Scientific The medical device company's still ahead of the competition. Companies dependent upon one product line may be riskier than average, but there's no question that they can reap big-time profits when business is good.
The Motley Fool October 13, 2008 Brian Orelli	Too Little Too Late for Boston Scientific The company gets new stent approved, but it should have happened earlier.
The Motley Fool May 25, 2005 W.D. Crotty	Medtronic's Sneak Preview The medical technology company, a 26-bagger, turns in another strong quarter and fiscal year, then offers quite an outlook.
The Motley Fool May 11, 2011 Brian Orelli	Boston Scientific Investors' Parting Gift Less than two years in, Elliot is out.
The Motley Fool July 21, 2010 Brian Orelli	Boston Scientific Bounces When you're as beaten-down as Boston Scientific, you seemingly have nowhere to go but up. There's also bankruptcy, but the beleaguered medical device maker seems far from that -- at least for now.
The Motley Fool August 18, 2005 Stephen D. Simpson	Medtronic Keeps the Beat Strong growth in the ICD and spinal businesses keep Medtronic running. The stock is trading more or less at par to the market with respect to its P/E-to-growth ratio. Investors must decide for themselves whether that's a fair price to pay.
The Motley Fool November 18, 2008 Brian Orelli	No Buffer for Medtronic Even though sales grew for the quarter, investors weren't happy.
The Motley Fool February 20, 2008 Brian Orelli	Medtronic Looks Ahead After a rough second half of last year, Medtronic is leaving its problems behind, and optimistically focusing on the future.